Literature DB >> 9041346

Persistent infection of human vascular endothelial cells by group B coxsackieviruses.

P G Conaldi1, C Serra, A Mossa, V Falcone, F Basolo, G Camussi, A Dolei, A Toniolo.   

Abstract

Group B coxsackieviruses (CVBs) cause >20% of the cases of myocarditis and dilated cardiomyopathy. Information on the permissiveness of vascular cells to CVBs is scant. Interactions of CVBs with human vascular endothelial cells (ECs) were investigated in vitro. All 6 CVBs (CVB-1 to -6) consistently infected primary EC cultures and an immortalized EC line without producing cytopathology. Whereas replication of types 1, 2, 4, and 6 ceased within 30-60 days after infection, CVB-3 and -5 caused a persistent infection. Replication of CVB-3 and -5 continued for >260 days. In ECs, the constitutive production of interferon-beta, but not of other cytokines, appeared to confer resistance to CVBs. Persistence of CVB-3 and -5 was associated with the chronic release of tumor necrosis factor-alpha, a cytotoxic cytokine that also has a negative inotropic effect on myocardial cells. The results suggest that chronic endothelial CVB infections may play a role in vascular disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041346     DOI: 10.1093/infdis/175.3.693

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density.

Authors:  S D Carson; J T Hobbs; S M Tracy; N M Chapman
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Persistent infection of human thymic epithelial cells by coxsackievirus B4.

Authors:  Fabienne Brilot; Wassim Chehadeh; Chantal Charlet-Renard; Henri Martens; Vincent Geenen; Didier Hober
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells.

Authors:  W Chehadeh; J Kerr-Conte; F Pattou; G Alm; J Lefebvre; P Wattré; D Hober
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Human astrocytic cells support persistent coxsackievirus B3 infection.

Authors:  Xiaowei Zhang; Zhenhua Zheng; Bo Shu; Xijuan Liu; Zhenfeng Zhang; Yan Liu; Bingke Bai; Qinxue Hu; Panyong Mao; Hanzhong Wang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

5.  Expression of Pax2 in human renal tumor-derived endothelial cells sustains apoptosis resistance and angiogenesis.

Authors:  Valentina Fonsato; Stefano Buttiglieri; Maria Chiara Deregibus; Valeria Puntorieri; Benedetta Bussolati; Giovanni Camussi
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

6.  Characterization of coxsackievirus B3 replication in human umbilical vein endothelial cells.

Authors:  A Kühnl; C Rien; K Spengler; N Kryeziu; A Sauerbrei; R Heller; A Henke
Journal:  Med Microbiol Immunol       Date:  2014-03-11       Impact factor: 3.402

7.  Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells.

Authors:  P G Conaldi; L Biancone; A Bottelli; A De Martino; G Camussi; A Toniolo
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

Review 8.  Immunopathology of the human pancreas in type-I diabetes.

Authors:  Sarah J Richardson; Abby Willcox; Adrian J Bone; Noel G Morgan; Alan K Foulis
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

9.  Cumulative mutations in the genome of Echovirus 6 during establishment of a chronic infection in precursors of glial cells.

Authors:  Frederik Beaulieux; Youssef Zreik; Christelle Deleage; Valerie Sauvinet; Vincent Legay; Pascale Giraudon; Katherine M Kean; Bruno Lina
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

10.  Analysis of pancreas tissue in a child positive for islet cell antibodies.

Authors:  M Oikarinen; S Tauriainen; T Honkanen; K Vuori; P Karhunen; C Vasama-Nolvi; S Oikarinen; C Verbeke; G E Blair; I Rantala; J Ilonen; O Simell; M Knip; H Hyöty
Journal:  Diabetologia       Date:  2008-08-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.